Villela Daniel, Leonhardt Julia, Patel Neal, Joseph Jason, Kirsch Sebastian, Hallberg Anders, Unger Thomas, Bader Michael, Santos Robson A, Sumners Colin, Steckelings U Muscha
†Center for Cardiovascular Research, Institute of Pharmacology, Charité-Medical Faculty Berlin, Berlin, Germany.
‡Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, U.S.A.
Clin Sci (Lond). 2015 Feb;128(4):227-34. doi: 10.1042/CS20130515.
The angiotensin type 2 receptor (AT2R) and the receptor Mas are components of the protective arms of the renin-angiotensin system (RAS), i.e. they both mediate tissue protective and regenerative actions. The spectrum of actions of these two receptors and their signalling mechanisms display striking similarities. Moreover, in some instances, antagonists for one receptor are able to inhibit the action of agonists for the respective other receptor. These observations suggest that there may be a functional or even physical interaction of both receptors. This article discusses potential mechanisms underlying the phenomenon of blockade of angiotensin-(1-7) [Ang-(1-7)] actions by AT2R antagonists and vice versa. Such mechanisms may comprise dimerization of the receptors or dimerization-independent mechanisms such as lack of specificity of the receptor ligands used in the experiments or involvement of the Ang-(1-7) metabolite alamandine and its receptor MrgD in the observed effects. We conclude that evidence for a functional interaction of both receptors is strong, but that such an interaction may be species- and/or tissue-specific and that elucidation of the precise nature of the interaction is only at the very beginning.
血管紧张素2型受体(AT2R)和Mas受体是肾素-血管紧张素系统(RAS)保护分支的组成部分,也就是说,它们都介导组织保护和再生作用。这两种受体的作用谱及其信号传导机制表现出惊人的相似性。此外,在某些情况下,一种受体的拮抗剂能够抑制另一种受体激动剂的作用。这些观察结果表明,这两种受体之间可能存在功能甚至物理相互作用。本文讨论了AT2R拮抗剂阻断血管紧张素-(1-7)[Ang-(1-7)]作用现象以及反之亦然的潜在机制。此类机制可能包括受体二聚化或非二聚化机制,如实验中使用的受体配体缺乏特异性,或观察到的效应涉及Ang-(1-7)代谢产物阿拉曼丁及其受体MrgD。我们得出结论,两种受体功能相互作用的证据确凿,但这种相互作用可能具有物种和/或组织特异性,且对相互作用确切性质的阐明才刚刚开始。